An international study led by a Catalan team of researchers finds that the vaccine is not only effective in women between the ages of 9 and 26 , but in women older than 26. Women up to 45 years old could use this preventative vaccine. The study is published this Wednesday in the ‘British Journal of Cancer’.
Researchers from Barcelona’s Hospital Clínic find other indicators about the beginning of Alzheimer’s. They recommend using alternative biomarkers to get an early diagnosis.
The Catalan scientist Jordi Sunyer is developing a research study on how children’s brains are affected by air pollution. The hypothesis is that pollution diminisihes children’s capacities to learn.
Among Barcelona’s biomedical cluster, a project is comparing the genomes of great apes in order to identify the common structures and differences with human DNA. The aim of the project is to use genomic science to find a cure for human illnesses.
The new drug, called ‘Eribulin’, improves the survival rate of patients with a metastasis from breast cancer by 20%. The drug has been developed by a multinational team lead by staff from Barcelona’s Vall d’Hebron Hospital. The study has been published in the reference medical journal ‘The Lancet’.
A year after setting up, the CNAG (National Centre for Genome Analysis) is the second most important DNA centre in Europe. It is located in Scientific Park of Barcelona and each day processes 100 Gigabytes of information, stored a 1.2 Petabyte supercomputer.
It is the most effective AIDS vaccine to date. It has been tested on HIV patients and reduces the viral load up by three times. It needs further test but in the future the new vaccine could replace the current retroviral treatments.